Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
International Journal of Molecular Sciences|May 14, 2025
The p130Cas-Crk/CrkL Axis: A Therapeutic Target for Invasive Cancers Unveiled by Collaboration Among p130Cas, Crk, and CrkLPegah Farhadi, Taeju ParkJournal of Visualized Experiments : Jove|July 10, 2023
Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA TransfectionTaeju Park, Neka LargeBiochemical and Biophysical Research Communications|August 2, 2020
Requirement for Crk and CrkL during postnatal lens developmentTaeju Park, Tom CurranCancers|September 13, 2025
Choice of Animal Models to Investigate Cell Migration and Invasion in GlioblastomaPiyanka Hettiarachchi, Taeju ParkThe Journal of Biological Chemistry|February 9, 2021
Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activityTaeju Park, Neka Large, Tom CurranJournal of Visualized Experiments : Jove|April 21, 2020
Impedance-based Real-time Measurement of Cancer Cell Migration and InvasionGiridhar Mudduluru, Neka Large, Taeju ParkThe Journal of Biological Chemistry|November 4, 2016
Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL)Taeju Park, Mateusz Koptyra, Tom CurranMethods in Enzymology|June 17, 2024
Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axisJustin T Douglas, David K Johnson, Anuradha Roy, et al.Cell Biochemistry and Function|April 30, 2002
dELL, a drosophila homologue of transcription elongation factor ELL (Eleven-nineteen Lysine rich Leukemia), is required for early developmentShahryar Khattak, Hogune Im, Taeju Park, et al.Pageof 2